Safety of rituximab therapy during twins' pregnancy

Rheumatology

Volumn 50, Issue 4, 2011, Pages 806-808

  Ton, Evelien ^a   Tekstra, Janneke ^a   Hellmann, Petra M ^a   Nuver Zwart, Ike H H ^b   Bijlsma, Johannes W J ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b DEVENTER HOSPITAL   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; DISEASE MODIFYING ANTIRHEUMATIC DRUG; DOXORUBICIN; GLUCOCORTICOID; PREDNISONE; RITUXIMAB; TUMOR NECROSIS FACTOR ALPHA INHIBITOR; VINCRISTINE;

B LYMPHOCYTE; BLOOD PLACENTA BARRIER; DRUG SAFETY; HUMAN; LETTER; NEWBORN DISEASE; NONHODGKIN LYMPHOMA; NONHUMAN; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; TWIN PREGNANCY;

ADULT; ANTIBODIES, MONOCLONAL, MURINE-DERIVED; ANTIRHEUMATIC AGENTS; B-LYMPHOCYTES; CLUBFOOT; ERYTHEMA; FEMALE; HUMANS; INCIDENCE; INFANT, NEWBORN; LYMPHOCYTE COUNT; PREGNANCY; PREGNANCY OUTCOME; RHEUMATIC FEVER; TWINS;

EID: 79952803890     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/keq403     Document Type: Letter

References (17)

1. Ostensen M, Khamashta M, Lockshin M et al. Anti-inflammatory and immunosuppressive drugs and reproduction. Arthritis Res Ther 2006;8:209.
2. Youinou P, Taher TE, Pers JO, Mageed RA, Renaudineau Y. B lymphocyte cytokines and rheumatic autoimmune disease. Arthritis Rheum 2009;60:1873-80.
3. Simister NE. Placental transport of immunoglobulin G. Vaccine 2003;21:3365-9.
4. Malek A. Ex vivo human placenta models: transport of immunoglobulin G and its subclasses. Vaccine 2003;21: 3362-4.
5. Schroder C, Azimzadeh AM, Wu G, Price JO, Atkinson JB, Pierson RN. Anti-CD20 treatment depletes B-cells in blood and lymphatic tissue of cynomolgus monkeys. Transpl Immunol 2003;12:19-28.
6. Pham T, Fautrel B, Gottenberg JE et al. Rituximab (MabThera) therapy and safety management. Clinical tool guide. Joint Bone Spine 2008;75(Suppl. 1):S1-99.
7. Ostensen M, Lockshin M, Doria A et al. Update on safety during pregnancy of biological agents and some immunosuppressive anti-rheumatic drugs. Rheumatology 2008;47(Suppl. 3):iii28-31.
8. Pereg D, Koren G, Lishner M. The treatment of Hodgkin's and non-Hodgkin's lymphoma in pregnancy. Haematologica 2007;92:1230-7.
9. Kimby E, Sverrisdottir A, Elinder G. Safety of rituximab therapy during the first trimester of pregnancy: a case history. Eur J Haematol 2004;72:292-5.
10. Ojeda-Uribe M, Gilliot C, Jung G, Drenou B, Brunot A. Administration of rituximab during the first trimester of pregnancy without consequences for the newborn. J Perinatol 2006;26:252-5.
11. Rey J, Coso D, Roger V et al. Rituximab combined with chemotherapy for lymphoma during pregnancy. Leuk Res 2009;33:e8-9.
12. Magloire LK, Pettker CM, Buhimschi CS, Funai EF. Burkitt's lymphoma of the ovary in pregnancy. Obstet Gynecol 2006;108:743-5.
13. Herold M, Schnohr S, Bittrich H. Efficacy and safety of a combined rituximab chemotherapy during pregnancy. J Clin Oncol 2001;19:389-97.
14. Friedrichs B, Tiemann M, Salwender H, Verpoort K, Wenger MK, Schmitz N. The effects of rituximab treatment during pregnancy on a neonate. Haematologica 2006;91: 1426-7.
15. Decker M, Rothermundt C, Hollander G, Tichelli A, Rochlitz C. Rituximab plus CHOP for treatment of diffuse large B-cell lymphoma during second trimester of pregnancy. Lancet Oncol 2006;7:693-4.
16. Scully M, Starke R, Lee R, Mackie I, Machin S, Cohen H. Successful management of pregnancy in women with a history of thrombotic thrombocytopaenic purpura. Blood Coagul Fibrinolysis 2006;17:459-63.
17. Klink DT, van Elburg RM, Schreurs MW, van Well GT. Rituximab administration in third trimester of pregnancy suppresses neonatal B-cell development. Clin Dev Immunol 2008;2008:271363.